Kyoto University Innovation Capital

RegCell focuses on developing innovative therapies by modulating or controlling the immune system. Its primary objective is to treat patients with autoimmune diseases and cancer.

JiMED develops a wireless embedded Brain-Computer Interface (BCI) system designed to read brain activity. The company offers an implantable device that uses artificial intelligence to interpret brain signals, enabling individuals with conditions like ALS to enhance communication and improve quality of life.

Holo Bio is a research and technology firm that specializes in biological breeding techniques to tackle global food challenges. The company has developed a novel organism breeding technology centered around the intestinal bacterium GI35, which was identified in the fish species endemic to Lake Biwa, Isaza. This innovative approach allows Holo Bio to enhance the productivity of polyunsaturated fatty acids (PUFAs) and supply eicosapentaenoic acid (EPA) derived from fish. By transforming previously inedible plant fibers into consumable products, Holo Bio aims to contribute to sustainable food solutions and improve the availability of nutritious resources for society.

Enu Pharma is a pharmaceutical company focused on innovative research and the development of advanced medicines aimed at improving global healthcare standards. The company specializes in nanosome technology, which is designed to assist medical professionals in treating intractable diseases. This technology features core metals enveloped in an antiadhesive mixed self-assembled monolayer, which helps prevent the non-specific surface protein corona that can hinder drug efficacy. By leveraging this unique approach, Enu Pharma aims to enhance drug discovery, development, and delivery, ultimately contributing to more effective treatment options for challenging medical conditions.

KOALA Tech is a high-tech company based in Fukuoka, Japan, focused on developing organic semiconductor laser diodes. Founded in 2019, it aims to enable practical applications of the world's first organic semiconductor laser diode realized at the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University. The company's laser diode technology is based on organic fluorescent semiconductors, which are generally easier to process into thin films, offering a potentially low-cost light source that can be integrated with organic light-emitting diode and other organic electronic platforms.

Rhinoflux is an energy management company specializing in advanced thermal management technologies for efficient cooling systems.

OOYOO is a technology company specializing in the research and development of advanced gas separation membranes. Their primary focus is on carbon dioxide and hydrogen separation, aiming to create cleaner and more efficient air and gas purification solutions. The company's innovative, compact, and portable systems are designed to help industries reduce operational costs and promote sustainability, catering to sectors involved in environmental preservation and clean energy initiatives.

Rege Nephro is a Kyoto-based biotechnology company focused on renal disease therapeutics. It conducts research and development, production, and marketing of therapies based on nephron progenitor cells, and develops kidney organoids used to screen nephrotoxicity in drug discovery. The company is leveraging induced pluripotent stem cell technology from the Center for iPS Cell Research and Application at Kyoto University to develop cell-based therapies for kidney conditions, along with potential applications for liver and pancreas diseases. Founded in 2019, Rege Nephro aims to reduce dialysis dependence by addressing renal failure through regenerative approaches.

RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a specialized radiation therapy that uses nuclear reactions between neutrons and boron-10 to destroy cancer cells.

Symbiobe is engaged in the development of a resource-recycling material production platform that aims to promote sustainability through the effective utilization of underutilized natural biomass resources and photosynthetic organisms. The company focuses on creating alternatives for greenhouse gas fixation and producing industrial biopolymers, nitrogen fertilizers, and aquaculture feed. By advancing manufacturing processes that prioritize environmental sustainability, Symbiobe supports the transition to a more sustainable society and provides essential resources for environmental start-up businesses seeking natural and sustainable products.

EneCoat Technologies, established in 2018 and headquartered in Kyoto, Japan, specializes in the manufacturing and sale of perovskite solar cells and associated materials. The company focuses on developing and commercializing thin-film solar cell technologies, aiming to generate power even in low-light conditions. EneCoat's mission is to protect the environment and efficiently harness natural energy sources, enabling businesses to conveniently produce energy from solar cells.

Grand Green, established in 2017 and headquartered in Nagoya, Japan, specializes in the production of new seeds and seedlings through automatic grafting techniques. As a research and development agribio venture, the company focuses on innovative approaches to enhance agricultural practices and improve crop yield. By leveraging advanced technology in seedling production, Grand Green aims to contribute to the agricultural sector's growth and sustainability.

RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a specialized radiation therapy that uses nuclear reactions between neutrons and boron-10 to destroy cancer cells.

Restore Vision is a biotechnology company focused on developing innovative therapies for eye diseases, particularly retinitis pigmentosa. The company specializes in gene therapy that employs advanced chimeric rhodopsin genes, which enhance the functionality of conventional rhodopsins. This technology aims to address the limitations of traditional treatments, providing high sensitivity and improved outcomes for patients suffering from intractable eye conditions. Through its research and development efforts, Restore Vision seeks to create effective therapeutic agents that significantly contribute to the field of ocular health.

Melody International specializes in developing medical equipment for remote healthcare services. Its flagship product is a fetal monitoring device designed to assist doctors during challenging deliveries, featuring a fetal heart monitor, uterine contraction monitor, and a tablet with internet connectivity.

QSimulate is a Boston-based company that specializes in developing cloud-based quantitative simulation tools focused on quantum molecular simulations. By leveraging the principles of quantum mechanics, QSimulate aims to address significant industrial-scale challenges primarily within the chemical and pharmaceutical sectors. Its innovative platform automates various workflows, allowing computational scientists to shift their focus from repetitive tasks to more strategic activities, ultimately enhancing productivity. This approach enables clients to accelerate their research and development processes, positioning QSimulate as a key player in advancing scientific inquiry and innovation in these industries.

Sunlit Seedlings is a consulting firm specializing in scientific fields such as mycology, integrated ecosystems, and network science. It offers services for diagnosing biological communities and ecosystems, aiming to promote sustainable food supply and environmental stabilization.

Symbiobe is engaged in the development of a resource-recycling material production platform that aims to promote sustainability through the effective utilization of underutilized natural biomass resources and photosynthetic organisms. The company focuses on creating alternatives for greenhouse gas fixation and producing industrial biopolymers, nitrogen fertilizers, and aquaculture feed. By advancing manufacturing processes that prioritize environmental sustainability, Symbiobe supports the transition to a more sustainable society and provides essential resources for environmental start-up businesses seeking natural and sustainable products.

Toregem BioPharma is a Kyoto, Japan-based startup spun out from Kyoto University that develops dental regenerative medicines. The company focuses on therapeutic agents for congenital adentia and aims to restore dentition by regenerating teeth from a patient’s own tissues, with research and development aimed at treating tooth loss due to decay or periodontal disease and improving oral health.

Viage Therapeutics is a neuroscience company established in 2018, focusing on the development of innovative neurotherapeutics. The company is dedicated to discovering and creating a new class of drugs aimed at treating psychiatric and inflammatory diseases, including conditions such as depression, anxiety, and gastrointestinal disorders. Through its groundbreaking research, Viage Therapeutics seeks to address significant unmet medical needs, providing healthcare professionals with access to novel therapeutic options that could improve patient outcomes.

Rege Nephro is a Kyoto-based biotechnology company focused on renal disease therapeutics. It conducts research and development, production, and marketing of therapies based on nephron progenitor cells, and develops kidney organoids used to screen nephrotoxicity in drug discovery. The company is leveraging induced pluripotent stem cell technology from the Center for iPS Cell Research and Application at Kyoto University to develop cell-based therapies for kidney conditions, along with potential applications for liver and pancreas diseases. Founded in 2019, Rege Nephro aims to reduce dialysis dependence by addressing renal failure through regenerative approaches.

BTB Drug Discovery Research Center aims to contribute to reducing illness and saving lives. They create the product concept (TPP) and develop the finest plans possible for R&D, intellectual property, and pharmaceutical affairs. The company is developing a therapeutic medicine using a unique mechanism of action that encourages the release of endogenous opioids.

Myoridge Co. Ltd., established in 2016 and headquartered in Kyoto, Japan, specializes in developing a suspension culture system for scalable differentiation of pluripotent cells into desired cell types, notably cardiomyocytes. The company's innovative process employs a proprietary small-molecule compound, eliminating the need for proteins, thereby reducing production costs and ensuring lot-to-lot uniformity. Myoridge offers iPS cell-derived cardiomyocytes, cardiomyocyte fibers, and software for myocardial motion/fluorescence analysis, enabling advancements in regenerative medicine and drug discovery research.

Melody International specializes in developing medical equipment for remote healthcare services. Its flagship product is a fetal monitoring device designed to assist doctors during challenging deliveries, featuring a fetal heart monitor, uterine contraction monitor, and a tablet with internet connectivity.

Cuorips Inc. is a medical care company based in Chuo, Japan, with an additional office in Osaka. Founded in 2017, it focuses on the research, development, and commercialization of iPS cell-derived cardiomyocyte sheets and various cell therapeutic products. The company offers manufacturing and sales of cellular and tissue-based products, along with contract development and manufacturing services. Cuorips aims to advance medical treatments through innovation in cell processing and therapeutic applications.

Perseus Proteomics Inc. is a biotechnology company based in Tokyo, Japan, focused on drug discovery. Established in 2001, it specializes in antibody discovery, engineering, and research support activities. The company engages in target discovery and functional protein expression, offering services such as mouse hybridoma sequencing, recombinant protein production, and contract research for antibodies. Additionally, Perseus Proteomics develops, manufactures, and supplies a range of antibody products. By leveraging advanced antibody technology, the company aims to create innovative medicines that address the needs of patients worldwide seeking improved medical care.

Founded in Kyoto, Japan in 2019, Kyoto Fusioneering is a privately funded technology company focused on developing advanced technologies for commercial fusion reactors. Their work includes gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. The company aims to accelerate the realization of fusion energy as a viable, carbon-free power source.

ACT Genomics is a cancer molecular information company that applies oncology, cancer genomics, and bioinformatics expertise to transform cancer genomic data into precision diagnosis and personalized treatment options. The company uses next-generation sequencing and multiplex molecular testing, combined with curated proprietary databases and data visualization tools, to profile tumors at the molecular level. This comprehensive profiling supports oncologists in selecting more effective therapies and predicting patient outcomes, with rapid advances in sequencing and informatics helping to make these insights more accessible.

Toregem BioPharma is a Kyoto, Japan-based startup spun out from Kyoto University that develops dental regenerative medicines. The company focuses on therapeutic agents for congenital adentia and aims to restore dentition by regenerating teeth from a patient’s own tissues, with research and development aimed at treating tooth loss due to decay or periodontal disease and improving oral health.

FLOSFIA INC. is a Tokyo-based company that focuses on the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the company emerged as a spin-off from research conducted at Kyoto University. FLOSFIA specializes in film-formation using mist chemical vapor deposition (CVD) techniques, leveraging the unique physical properties of gallium oxide (Ga2O3) to create high breakdown voltage and high efficiency power devices. The firm is dedicated to advancing low-loss power device technology, contributing to the evolution of semiconductor applications.

U-MaP Co., Ltd. is a manufacturer based in Nagoya, Japan, specializing in aluminum nitride (AlN) whiskers designed for thermal management and heat dissipation applications. Established in 2016, the company originates from research initiatives at Nagoya University and focuses on commercializing advanced materials and processing technologies. U-MaP is committed to addressing global challenges in manufacturing by developing conductive materials with high thermal conductivity and insulating properties. This innovative approach aims to enhance product quality and sustainability across various industries, positioning U-MaP as a key player in the development of next-generation industrial materials.

Rege Nephro is a Kyoto-based biotechnology company focused on renal disease therapeutics. It conducts research and development, production, and marketing of therapies based on nephron progenitor cells, and develops kidney organoids used to screen nephrotoxicity in drug discovery. The company is leveraging induced pluripotent stem cell technology from the Center for iPS Cell Research and Application at Kyoto University to develop cell-based therapies for kidney conditions, along with potential applications for liver and pancreas diseases. Founded in 2019, Rege Nephro aims to reduce dialysis dependence by addressing renal failure through regenerative approaches.

Fimecs is a biotechnology company that specializes in drug discovery focused on protein degradation technology. The firm aims to develop first-in-class therapeutics targeting the degradation of proteins associated with cancers and other challenging diseases. Utilizing a proprietary platform based on ubiquitin E3 ligase binders, Fimecs designs small molecules that can induce the degradation of specific proteins, many of which are considered undruggable. This innovative approach targets proteins linked to various diseases, expanding the potential for effective treatment options beyond the traditionally druggable targets identified in small molecule drug discovery. Through its emphasis on targeted protein degradation, Fimecs is positioned to contribute significantly to the advancement of anti-cancer therapies and the treatment of other hard-to-treat conditions.

EneCoat Technologies, established in 2018 and headquartered in Kyoto, Japan, specializes in the manufacturing and sale of perovskite solar cells and associated materials. The company focuses on developing and commercializing thin-film solar cell technologies, aiming to generate power even in low-light conditions. EneCoat's mission is to protect the environment and efficiently harness natural energy sources, enabling businesses to conveniently produce energy from solar cells.

Founded in Tokyo, Japan in 2012, Tiem Factory specializes in the research, development, manufacturing, and sale of aerogel under the brand SUFA. The company's primary product is an ultra-light transparent insulation material designed for thermal insulation applications.

LegalForce, Inc. is a Tokyo-based company founded in 2017 that specializes in developing software for legal services. It operates an AI-powered contract management platform designed to assist legal professionals in contract review. By utilizing natural language processing and other advanced technologies, LegalForce's platform helps users analyze contracts based on their specific types, while identifying potentially omitted or risky clauses. This functionality aids legal professionals in preventing oversights and enhancing the quality and efficiency of their operations, ultimately strengthening their legal systems.

LegalOn is an AI-driven platform specializing in contract review. It leverages AI, legal content, and team knowledge to identify potential risks, suggest redlines, and structure contract data, thereby enhancing efficiency in legal processes.

Founded in Kyoto, Japan in 2019, Kyoto Fusioneering is a privately funded technology company focused on developing advanced technologies for commercial fusion reactors. Their work includes gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. The company aims to accelerate the realization of fusion energy as a viable, carbon-free power source.

Myoridge Co. Ltd., established in 2016 and headquartered in Kyoto, Japan, specializes in developing a suspension culture system for scalable differentiation of pluripotent cells into desired cell types, notably cardiomyocytes. The company's innovative process employs a proprietary small-molecule compound, eliminating the need for proteins, thereby reducing production costs and ensuring lot-to-lot uniformity. Myoridge offers iPS cell-derived cardiomyocytes, cardiomyocyte fibers, and software for myocardial motion/fluorescence analysis, enabling advancements in regenerative medicine and drug discovery research.

Luxonus is a medical device company focused on imaging technology that combines light and ultrasound to produce ultra-high-resolution 3D images of blood vessels and lymphatic networks. It develops a photoacoustic imaging platform designed for early detection and diagnosis of diseases, enabling clinicians to gain a comprehensive view of disease onset, progression, and recovery with non-invasive visualization and no radiation exposure.

Thyas Co. Ltd., established in 2015, specializes in developing personalized regenerative immunocell therapies to treat cancer and infections. The company's core business involves generating regenerative T cells from human induced pluripotent stem (iPS) cells, aiming to enhance patients' immune systems for combating various diseases.

Algal Bio Co., Ltd., established in 2018, is a Japanese company specializing in the research, development, production, and sale of algae and its components. Headquartered in Kashiwa, Japan, the company focuses on extracting rare fatty acids and carotenoids from algae, operating within food processing, importing, exporting, and distributing algae-related ingredients. Algal Bio was founded upon two decades of research from the University of Tokyo, aiming to harness microalgae's potential as functional food ingredients.

AceRNA Technologies is a biotechnology startup focused on developing patient-centric genetic therapies using its proprietary RNA switch technology for drug discovery. The company specializes in regenerative medicine, aiming to control gene expression with novel microRNA functions. Its innovative approach enables the removal of undifferentiated cells and other unnecessary cells that pose cancer risks, thereby advancing personalized healthcare solutions.

Thyas Co. Ltd., established in 2015, specializes in developing personalized regenerative immunocell therapies to treat cancer and infections. The company's core business involves generating regenerative T cells from human induced pluripotent stem (iPS) cells, aiming to enhance patients' immune systems for combating various diseases.

Space Power Technologies is a Japanese company founded in 2019, specializing in the development and manufacturing of microwave-based wireless power transmission systems. As Japan's first start-up focused on spatial transmission wireless power transmission, the company aims to address societal power supply challenges by integrating advanced technologies with practical applications. Its innovative systems offer diverse usage scenarios, including factories, logistics sites, infrastructure monitoring, depopulated areas lacking power wiring, disaster recovery situations, and even outer space. By enabling wireless power transfer over distances using radio waves, Space Power Technologies seeks to contribute to the creation of a wireless society, enhancing efficiency and accessibility in power delivery.

Kyulux is a material developer that researches and sells organic electroluminescence materials for OLED displays and lighting. The company specializes in thermally activated delayed fluorescence (TADF) emitters and Hyperfluorescence technology that combines TADF with fluorescent emitters to achieve high efficiency. Kyulux develops and supplies OLED materials and related solutions to manufacturers in the display and lighting industries, enabling cost-effective, durable, and efficient OLED devices without rare metals. Founded in 2015 and headquartered in Fukuoka, Japan, Kyulux owns or controls a substantial portfolio of TADF intellectual property developed with Kyushu University and industry partners, supporting the commercial adoption of next-generation OLEDs.

On the way to Sakano deliver vegetables grown without the use of pesticides and chemical fertilizers, aiming to spread agriculture with low environmental impact. We want to make agriculture sustainable and reach a sustainable society.

Sho Engineering specializes in planning, research, and product development for wireless transmission equipment. Its products aim to enhance safety and security, including data transmitters, wireless power devices, and remote monitoring systems.

AlphaNavi Pharma Co., Ltd. is a biotechnology company based in Kyoto, Japan, founded in 2019. The company focuses on drug discovery, specifically developing novel therapeutics for pain management. It is engaged in research and development of voltage-gated sodium channel selective inhibitors, with its primary products being ANP-230 and ANP-231, which are aimed at treating peripheral neuropathic pain. AlphaNavi Pharma collaborates with academic institutions and investors to enhance its research and clinical development efforts, striving to create innovative analgesic drugs that alleviate pain for patients and improve their quality of life.

Chordia Therapeutics Inc. is a clinical-stage biotechnology company based in Fujisawa, Japan, founded in 2017. The company specializes in the research and development of innovative oncology drugs, focusing on delivering first-in-class therapies for cancers that currently have high unmet medical needs. Chordia Therapeutics is committed to advancing new therapeutic options to patients as swiftly as possible, aiming to address significant gaps in cancer treatment.

Luxonus is a medical device company focused on imaging technology that combines light and ultrasound to produce ultra-high-resolution 3D images of blood vessels and lymphatic networks. It develops a photoacoustic imaging platform designed for early detection and diagnosis of diseases, enabling clinicians to gain a comprehensive view of disease onset, progression, and recovery with non-invasive visualization and no radiation exposure.

SOUSEI Technology, Inc., established in 2018 and headquartered in Tokyo, specializes in developing innovative home design and management solutions. The company offers an IoT device called v-ex, enabling voice-activated communication with home electronics. Additionally, SOUSEI provides Knot, an online platform facilitating connections between housing companies and homeowners while streamlining customer and property information management, documents, and security compliance.

LegalOn is an AI-driven platform specializing in contract review. It leverages AI, legal content, and team knowledge to identify potential risks, suggest redlines, and structure contract data, thereby enhancing efficiency in legal processes.

EneCoat Technologies, established in 2018 and headquartered in Kyoto, Japan, specializes in the manufacturing and sale of perovskite solar cells and associated materials. The company focuses on developing and commercializing thin-film solar cell technologies, aiming to generate power even in low-light conditions. EneCoat's mission is to protect the environment and efficiently harness natural energy sources, enabling businesses to conveniently produce energy from solar cells.

LegalForce, Inc. is a Tokyo-based company founded in 2017 that specializes in developing software for legal services. It operates an AI-powered contract management platform designed to assist legal professionals in contract review. By utilizing natural language processing and other advanced technologies, LegalForce's platform helps users analyze contracts based on their specific types, while identifying potentially omitted or risky clauses. This functionality aids legal professionals in preventing oversights and enhancing the quality and efficiency of their operations, ultimately strengthening their legal systems.

Mitsucari is an HR technology service company that specializes in enhancing organizational effectiveness by analyzing individual personalities and compatibility within corporate environments. It has developed a candidate verification platform that assesses job seekers' personalities through aptitude tests while concurrently evaluating existing employees to understand the corporate culture. This dual analysis helps to identify compatibility between candidates and organizations, facilitating better job matching. By focusing on personality traits and desired work conditions, Mitsucari aims to improve the hiring process for employers and assist job seekers in finding positions that align with their values and preferences, ultimately contributing to employee retention and satisfaction.

AceRNA Technologies is a biotechnology startup focused on developing patient-centric genetic therapies using its proprietary RNA switch technology for drug discovery. The company specializes in regenerative medicine, aiming to control gene expression with novel microRNA functions. Its innovative approach enables the removal of undifferentiated cells and other unnecessary cells that pose cancer risks, thereby advancing personalized healthcare solutions.

Connexx Systems Corporation is a Kyoto-based company that specializes in the development and manufacturing of power storage systems, including household and mobile storage solutions for emergencies. Established in 2011, the company integrates core battery technologies with power generation facilities, utilizing renewable energy sources such as solar and wind power to provide alternative energy solutions. Connexx Systems markets its products through distributors and constructors, as well as through catalogs, offering innovative options for electric power generation and storage. With additional offices in Tokyo and Fukuoka, Connexx Systems aims to enhance energy accessibility and sustainability.

Cuorips Inc. is a medical care company based in Chuo, Japan, with an additional office in Osaka. Founded in 2017, it focuses on the research, development, and commercialization of iPS cell-derived cardiomyocyte sheets and various cell therapeutic products. The company offers manufacturing and sales of cellular and tissue-based products, along with contract development and manufacturing services. Cuorips aims to advance medical treatments through innovation in cell processing and therapeutic applications.

Sho Engineering specializes in planning, research, and product development for wireless transmission equipment. Its products aim to enhance safety and security, including data transmitters, wireless power devices, and remote monitoring systems.

LegalForce, Inc. is a Tokyo-based company founded in 2017 that specializes in developing software for legal services. It operates an AI-powered contract management platform designed to assist legal professionals in contract review. By utilizing natural language processing and other advanced technologies, LegalForce's platform helps users analyze contracts based on their specific types, while identifying potentially omitted or risky clauses. This functionality aids legal professionals in preventing oversights and enhancing the quality and efficiency of their operations, ultimately strengthening their legal systems.

LegalOn is an AI-driven platform specializing in contract review. It leverages AI, legal content, and team knowledge to identify potential risks, suggest redlines, and structure contract data, thereby enhancing efficiency in legal processes.

AFI Technology is a Seoul-based developer and manufacturer of inspection and monitoring technology for science, engineering, medicine, and the environment. The company offers electric filter separation technology and rapid detection systems for microbial contamination risk monitoring, and provides products designed for rapid microbiological testing and environment-oriented solutions.

Questetra, Inc. is an enterprise cloud computing company based in Kyoto, Japan, founded in 2008. It specializes in providing business process management (BPM) tools designed to enhance productivity and optimize various workflows for organizations. The Questetra BPM Suite allows users to independently develop and manage BPMN-driven workflows through a 100% web-based interface, enabling both process design and task execution directly in a browser. The platform includes a variety of sample processes, such as estimate generation and invoice issuance, and offers seamless integration with Google Apps, allowing users to log in with their Google accounts and export data to Google Docs. Additionally, Questetra provides BPM consulting services to further support organizations in their process improvement initiatives.

Chordia Therapeutics Inc. is a clinical-stage biotechnology company based in Fujisawa, Japan, founded in 2017. The company specializes in the research and development of innovative oncology drugs, focusing on delivering first-in-class therapies for cancers that currently have high unmet medical needs. Chordia Therapeutics is committed to advancing new therapeutic options to patients as swiftly as possible, aiming to address significant gaps in cancer treatment.

Thyas Co. Ltd., established in 2015, specializes in developing personalized regenerative immunocell therapies to treat cancer and infections. The company's core business involves generating regenerative T cells from human induced pluripotent stem (iPS) cells, aiming to enhance patients' immune systems for combating various diseases.

Stem Cell & Device Laboratory, Inc. is a research and development company based in Kyoto, Japan, focused on the manufacturing and sale of cells, devices, and integrated products that utilize cell materials for drug discovery applications. Founded in 2014, the company specializes in developing innovative scaffold materials that demonstrate functional and cell compatibility, particularly for studies involving pluripotent stem cells. By leveraging advanced micro-engineering and nanofabrication technologies, Stem Cell & Device Laboratory aims to contribute to advancements in cell application products that support the health and well-being of society.

Oligogen is a bio-venture based in Kyoto, Japan, founded in 2015. The company focuses on drug development and regenerative medicine, specifically utilizing neural stem cell technologies to create therapies for patients with central nervous system diseases. Oligogen aims to treat conditions such as spinal cord injuries and other neurological disorders, including congenital leukoplakia and multiple sclerosis. By harnessing the potential of human neural stem cells, Oligogen seeks to provide effective cell therapies that enhance neurological healthcare for affected individuals.

Thyas Co. Ltd., established in 2015, specializes in developing personalized regenerative immunocell therapies to treat cancer and infections. The company's core business involves generating regenerative T cells from human induced pluripotent stem (iPS) cells, aiming to enhance patients' immune systems for combating various diseases.

Connexx Systems Corporation is a Kyoto-based company that specializes in the development and manufacturing of power storage systems, including household and mobile storage solutions for emergencies. Established in 2011, the company integrates core battery technologies with power generation facilities, utilizing renewable energy sources such as solar and wind power to provide alternative energy solutions. Connexx Systems markets its products through distributors and constructors, as well as through catalogs, offering innovative options for electric power generation and storage. With additional offices in Tokyo and Fukuoka, Connexx Systems aims to enhance energy accessibility and sustainability.

NS Materials Corp. is a manufacturer and distributor of semiconductor-related equipment and systems, located in Chikushino-shi, Japan. The company focuses on the development of micro-space chemical technologies, particularly in the area of nano-phosphor for LED lighting. Additionally, NS Materials specializes in chemical synthesis technologies that aim to advance nanotechnology and biotechnology. By creating innovative tools and products, the company contributes to the promotion of a low-carbon society and seeks to significantly impact people's lives.

FLOSFIA INC. is a Tokyo-based company that focuses on the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the company emerged as a spin-off from research conducted at Kyoto University. FLOSFIA specializes in film-formation using mist chemical vapor deposition (CVD) techniques, leveraging the unique physical properties of gallium oxide (Ga2O3) to create high breakdown voltage and high efficiency power devices. The firm is dedicated to advancing low-loss power device technology, contributing to the evolution of semiconductor applications.

Founded in Tokyo, Japan in 2012, Tiem Factory specializes in the research, development, manufacturing, and sale of aerogel under the brand SUFA. The company's primary product is an ultra-light transparent insulation material designed for thermal insulation applications.

Audio Metaverse is a pioneering developer of an audio streaming application that merges physical reality with the virtual realm through innovative 3D audio spaces. The platform, known as Cubemint, allows users to mint NFTs and explore these immersive audio environments collaboratively. It specializes in facilitating real-time conversations among friends and followers, streaming live audio sessions for extended periods while enabling users to respond to comments dynamically. By integrating augmented audio reality, Audio Metaverse enhances the experience of physical spaces through corresponding digital audio environments, allowing users to share and express ideas authentically while interacting with their digital assets.

PrediXT is a developer of prediction technologies.

Mitsucari is an HR technology service company that specializes in enhancing organizational effectiveness by analyzing individual personalities and compatibility within corporate environments. It has developed a candidate verification platform that assesses job seekers' personalities through aptitude tests while concurrently evaluating existing employees to understand the corporate culture. This dual analysis helps to identify compatibility between candidates and organizations, facilitating better job matching. By focusing on personality traits and desired work conditions, Mitsucari aims to improve the hiring process for employers and assist job seekers in finding positions that align with their values and preferences, ultimately contributing to employee retention and satisfaction.

Lang-8, Inc. is a Tokyo-based company founded in 2007 that operates a language exchange social networking platform designed to enhance language learning through community interaction. The platform allows users to write journal entries in the language they are learning, which are then corrected by native speakers. This reciprocal learning process enables users to improve their writing skills while also assisting others in their language acquisition. Lang-8 supports over 70 languages and boasts a diverse community of users from 180 countries, fostering a global environment for cultural and linguistic exchange. The company utilizes computer-assisted language learning technology to facilitate this educational experience, making it accessible for learners at various proficiency levels.

Founded in Tokyo in 2005, KinoPharma specializes in the discovery and development of small molecule drugs targeting Ser/Thr kinases. The company focuses on developing clinical drugs with minimal side effects through collaborative research with universities.

Kyoto Drug Discovery and Development Co. Ltd., based in Kyoto, Japan, specializes in the development of innovative therapeutic drugs targeting chronic degenerative eye diseases. The company focuses on creating effective treatments for conditions such as glaucoma, central retinal artery occlusion, retinal pigmentosa, and age-related macular degeneration. By addressing these intractable eye diseases, Kyoto Drug Discovery and Development aims to provide healthcare professionals with advanced options to improve patient outcomes and manage debilitating ocular conditions.

AFI Technology is a Seoul-based developer and manufacturer of inspection and monitoring technology for science, engineering, medicine, and the environment. The company offers electric filter separation technology and rapid detection systems for microbial contamination risk monitoring, and provides products designed for rapid microbiological testing and environment-oriented solutions.

Stem Cell & Device Laboratory, Inc. is a research and development company based in Kyoto, Japan, focused on the manufacturing and sale of cells, devices, and integrated products that utilize cell materials for drug discovery applications. Founded in 2014, the company specializes in developing innovative scaffold materials that demonstrate functional and cell compatibility, particularly for studies involving pluripotent stem cells. By leveraging advanced micro-engineering and nanofabrication technologies, Stem Cell & Device Laboratory aims to contribute to advancements in cell application products that support the health and well-being of society.